TuHURA BIOSCIENCES, INC./NV Adjustment of Warrants Granted for Services
TuHURA BIOSCIENCES, INC./NV (HURA) reported Adjustment of Warrants Granted for Services of $35.00 thousand for the 12-month period ending 2022-06-30, per its 10-K filed 2023-09-18.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:AdjustmentOfWarrantsGrantedForServices · last filed 2023-09-18
- TuHURA BIOSCIENCES, INC./NV adjustment of warrants granted for services for the quarter ending 2021-12-31 was $4.00K, a 97.81% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV adjustment of warrants granted for services for the quarter ending 2021-09-30 was $31.00K, a 31.11% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV adjustment of warrants granted for services for the quarter ending 2021-03-31 was $210.00K, a 112.12% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV adjustment of warrants granted for services for the quarter ending 2020-12-31 was $183.00K, a 422.86% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV adjustment of warrants granted for services for fiscal 2022 was $35.00K, a 93.85% decline from fiscal 2021.
- TuHURA BIOSCIENCES, INC./NV adjustment of warrants granted for services for fiscal 2021 was $569.00K, a 98.26% increase from fiscal 2020.
- TuHURA BIOSCIENCES, INC./NV adjustment of warrants granted for services for fiscal 2020 was $287.00K, a 1110.20% increase from fiscal 2019.
- TuHURA BIOSCIENCES, INC./NV adjustment of warrants granted for services for fiscal 2019 was $23.71K, a 87.67% decline from fiscal 2018.
| Period end | Adjustment of Warrants Granted for Services 3 month | Adjustment of Warrants Granted for Services 3 month as first filed | Adjustment of Warrants Granted for Services 6 month | Adjustment of Warrants Granted for Services 9 month | Adjustment of Warrants Granted for Services 12 month | Adjustment of Warrants Granted for Services 12 month as first filed | Adjustment of Warrants Granted for Services 14 month | Adjustment of Warrants Granted for Services 36 month | Adjustment of Warrants Granted for Services 42 month | Adjustment of Warrants Granted for Services 45 month | Adjustment of Warrants Granted for Services 48 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-30 | $35.00K 10-K · filed 2023-09-18 | ||||||||||
| 2021-12-31 | $4.00K 10-Q · filed 2023-05-11 | $35.00K derived: sum of 2 quarters · filed 2023-05-11 | |||||||||
| 2021-09-30 | $31.00K 10-Q · filed 2023-05-11 | ||||||||||
| 2021-06-30 | $569.00K 10-K · filed 2022-09-27 | ||||||||||
| 2021-03-31 | $210.00K 10-Q · filed 2022-05-13 | $393.00K derived: sum of 2 quarters · filed 2022-05-13 | $438.00K derived: sum of 3 quarters · filed 2022-05-13 | ||||||||
| 2020-12-31 | $183.00K 10-Q · filed 2022-05-13 | $228.00K derived: sum of 2 quarters · filed 2022-05-13 | |||||||||
| 2020-09-30 | $45.00K 10-Q · filed 2022-05-13 | ||||||||||
| 2020-06-30 | $287.00K 10-K · filed 2021-09-28 | $287.18K 10-K · filed 2020-09-18 | |||||||||
| 2020-03-31 | $99.00K 10-Q · filed 2021-05-13 | $98.63K 10-Q · filed 2020-05-13 | $134.00K derived: sum of 2 quarters · filed 2021-05-13 | ||||||||
| 2019-12-31 | $35.00K 10-Q · filed 2021-05-13 | $34.67K 10-Q · filed 2020-02-13 | |||||||||
| 2019-06-30 | $23.71K 10-K · filed 2020-09-18 | ||||||||||
| 2019-03-31 | $8.73K 10-Q · filed 2020-05-13 | $5.87K derived: sum of 2 quarters · filed 2020-05-13 | $36.53K derived: sum of 3 quarters · filed 2020-05-13 | ||||||||
| 2018-12-31 | -$2.86K 10-Q · filed 2020-05-13 | $27.80K derived: sum of 2 quarters · filed 2020-05-13 | |||||||||
| 2018-09-30 | $30.66K 10-Q · filed 2020-05-13 | ||||||||||
| 2018-06-30 | $192.40K 10-K · filed 2019-09-09 | ||||||||||
| 2017-06-30 | $81.60K 8-K · filed 2019-06-03 | ||||||||||
| 2016-06-30 | $277.06K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-27 | $495.87K derived: sum of 2 quarters · filed 2017-09-27 | $670.79K derived: sum of 3 quarters · filed 2017-09-27 | $677.45K 10-K · filed 2017-09-27 | |||||||
| 2016-03-31 | $218.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | $393.74K derived: sum of 2 quarters · filed 2016-05-12 | $400.39K 10-Q · filed 2016-05-12 | ||||||||
| 2015-12-31 | $174.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-12 | $181.57K 10-Q · filed 2016-02-12 | |||||||||
| 2015-09-30 | $6.65K 10-Q · filed 2015-11-16 | ||||||||||
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-16 | $0.00 derived: sum of 2 quarters · filed 2015-11-16 | $15.50K derived: sum of 3 quarters · filed 2015-11-16 | $124.02K 10-K · filed 2015-11-16 | |||||||
| 2014-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $15.50K derived: sum of 2 quarters · filed 2015-05-15 | $124.02K 10-Q · filed 2015-05-15 | $173.40K 10-Q · filed 2014-05-15 | |||||||
| 2013-12-31 | $15.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-12 | $124.02K 10-Q · filed 2015-02-12 | $124.02K 10-K · filed 2014-08-28 | $173.40K 10-K · filed 2014-03-10 | |||||||
| 2013-09-30 | $108.52K 10-Q · filed 2014-11-07 | $108.52K 10-Q · filed 2013-11-08 | $157.90K 10-Q · filed 2013-11-08 | ||||||||
| 2013-06-30 | $49.38K 10-Q · filed 2013-08-12 | ||||||||||
| 2013-03-31 | $49.38K 10-Q · filed 2013-05-15 | ||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-28 | $0.00 derived: sum of 2 quarters · filed 2014-08-28 | $0.00 derived: sum of 3 quarters · filed 2014-08-28 | $49.38K 10-K · filed 2014-08-28 | |||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $0.00 derived: sum of 2 quarters · filed 2013-11-08 | $49.38K 10-Q · filed 2013-11-08 | ||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $49.38K 10-Q · filed 2013-08-12 | |||||||||
| 2012-03-31 | $49.38K 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |